Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:

NCT ID: NCT06023134 Active, not recruiting - Clinical trials for Pulmonary Hypertension

Clinical Characteristics and Outcomes of Patients With Pulmonary Hypertension Associated Right Heart Failure

Start date: January 1, 2015
Phase:
Study type: Observational

The study aims to describe the clinical characteristics and clarify the predictors of the short- and long-term outcomes of RHF patients, further assist the diagnosis, risk stratification and treatment of RHF.

NCT ID: NCT06019715 Active, not recruiting - Clinical trials for Hypertensive Disorder of Pregnancy

Remote Postpartum Intervention Targeting Movement Behaviors After Hypertensive Disorders of Pregnancy

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to test the feasibility, acceptability, and preliminary efficacy of a postpartum physical activity intervention after a pregnancy complicated by a Hypertensive Disorder of Pregnancy. The study will also assess the effects of the remote postpartum intervention on blood pressure. To do this, we will recruit individuals that are 3-6 months postpartum a pregnancy complicated by a hypertensive disorder to participate in a 4-month health coaching intervention aimed to promote physical activity and was informed by formative work done previously.

NCT ID: NCT06003244 Active, not recruiting - Clinical trials for Chronic Thromboembolic Pulmonary Hypertension

High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)

Start date: September 23, 2023
Phase: N/A
Study type: Interventional

The investigators aim to study the effect of SOT in participants with pulmonary vascular diseases (PVD) defined as pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension (PH) who permanently live >2500m on 6-minute walk distance (6MWD) assessed at 2840m.

NCT ID: NCT05996302 Active, not recruiting - Clinical trials for Chronic Thromboembolic Pulmonary Hypertension

HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)

Start date: July 5, 2023
Phase: N/A
Study type: Interventional

To study the effect of relocation from 2840m (Quito) to sea level (Pedernales) in patients with pulmonary vascular diseases (PVD) defined as pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension (PH) who permanently live >2500m on 6-minute walk distance (6MWD)

NCT ID: NCT05972785 Active, not recruiting - Breast Cancer Clinical Trials

Long-term Use of CCB and Breast Cancer Risk

Start date: July 1, 2022
Phase:
Study type: Observational

The goal of this retrospective observational study is to examine whether long-term calcium channel blocker (CCB) use is associated with the development of breast cancer amongst women enrolled in three longitudinal cohort studies in Australia and the Netherlands . The main questions it aims to answer are: - Is long-term CCB use associated with the development of breast cancer amongst women enrolled in three longitudinal cohort studies in Australia and the Netherlands and what is the dose-response nature of this association. - Does differences in the association between calcium channel blocker use and the development of breast cancer exist between Australian and Dutch women. The investigators will utilise data from the Australian Longitudinal Study on Women's Health (ALSWH) , 45 and Up Study and Rotterdam study.

NCT ID: NCT05929170 Active, not recruiting - Hypertension Clinical Trials

Comparison of Extremely Obese Patients Undergoing Gastric Sleeve Surgery

Start date: April 1, 2021
Phase:
Study type: Observational

By the comparison of the preoperative and postoperative data of approximately 160 patients undergoing gastric sleeve surgery, we try to draw conclusions about the effectiveness of gastric sleeve surgery, expected complication rate.

NCT ID: NCT05912322 Active, not recruiting - Inflammation Clinical Trials

Evaluation of Black Chokeberry Bio Juice on Blood Pressure Levels and Endothelial Damage

AROBLENDO
Start date: June 1, 2022
Phase: N/A
Study type: Interventional

In Romania, the diseases of the circulatory system account for 59.3% of deaths, representing the main cause of morbidity and mortality. Barriers of current pharmacological treatments materialized in side effects and limited actions on risk factors increase the necessity of finding more effective, multi-target and less toxic therapeutic strategies. Considering the well-known benefits, natural compounds represent a very important source for drug candidates. The latest in vitro and in vivo studies on Aronia melanocarpa (Michx.) Elliott have highlighted its antioxidant, anti-inflammatory, anti-proliferative, anti-atherosclerotic, hypotensive, antiplatelet, lipid and glucose reduction properties, making it an excellent candidate for the prevention and treatment of cardiovascular and metabolic disorders. The aim of this study is to comprehensive evaluate (in vivo) the Aronia melanocarpa bio juice, obtained from Romania on blood pressure levels and endothelial damage.

NCT ID: NCT05887180 Active, not recruiting - Type 2 Diabetes Clinical Trials

PräVaNet - Structured, Intersectoral, Multiprofessional, Digitized Program to Optimize Cardiovascular Prevention

PräVaNet
Start date: January 1, 2022
Phase: N/A
Study type: Interventional

PräVaNet is a prospective, 1:1 randomized, controlled trial to investigate the efficacy of a new, digitalized prevention strategy ("ePrevention") in cardiovascular high-risk patients with type 2 diabetes mellitus in the outpatient sector.

NCT ID: NCT05867914 Active, not recruiting - Clinical trials for Hypertension, Pulmonary

Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD

EFS
Start date: December 4, 2023
Phase: N/A
Study type: Interventional

A trial to evaluate the safety, tolerability, and functionality of 3P-100, in subjects with Pulmonary Hypertension (PH) accompanying Interstitial Lung Disease (ILD), PH-ILD

NCT ID: NCT05843682 Active, not recruiting - Clinical trials for Essential Hypertension

Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2

Hyper2
Start date: October 7, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of the use of artificial intelligence in home monitoring in patients with uncontrolled arterial hypertension.